Chem.Ns

CHEM.NS maintains a strong liquidity position, with a current ratio of 2.23, indicating the company can cover its short-term obligations more than twice over. The company's debt-to-equity ratio is 0.02, suggesting a conservative capital structure with minimal reliance on debt financing. Free cash flow of $111.33 million supports operational flexibility and potential reinvestment.

Profitability metrics show a return on equity of 11.25% and a return on assets of 8.71%, both exceeding the industry median for specialty chemicals, which typically range between 8% and 10%. Operating income of $127.11 million and a gross profit of $767.25 million reflect strong cost control and pricing power.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. No material revenue is attributed to international markets, suggesting a domestic focus.

Looking ahead, revenue is projected to grow by 4.5% in the current fiscal year and 3.2% in the next, driven by stable demand in the industrial chemicals sector. However, the absence of disclosed new product launches or market expansion plans limits upside potential.

Risk factors include a medium liquidity risk due to a negative net cash position after subtracting total debt, and a low dilution risk, with no recent share issuance or shelf registration activity. The company's capital expenditure of -$43.71 million indicates asset sales or write-downs, which may signal strategic restructuring.

Recent filings and transcripts show no material changes in business strategy or financial outlook. The company has not disclosed any new partnerships, product launches, or regulatory challenges in the latest 10-K or earnings call transcripts.